The largest database of trusted experimental protocols

Akta purifier fplc system

Manufactured by GE Healthcare
Sourced in Canada

The AKTA Purifier FPLC system is a fast protein liquid chromatography (FPLC) instrument designed for the purification of proteins and other biomolecules. It is a versatile tool that can be used in various research and development applications, including protein purification, enzyme purification, and the separation of biological molecules.

Automatically generated - may contain errors

23 protocols using akta purifier fplc system

1

Size Exclusion Chromatography of Peptide Fractions

Check if the same lab product or an alternative is used in the 5 most similar protocols
The molecular weight distribution of AF1–AF5 was carried out using size exclusion chromatography as previously described [27 (link)] on an FPLC AKTA purifier system (GE Healthcare, Montreal, PQ, Canada) coupled with a Superdex 75 10 / 300 GL column. The column was equilibrated with 50 mM sodium phosphate buffer containing 150 mM NaCl (pH 7.2). A 1 mL aliquot of each sample (100 mg/mL) was eluted at a flow rate of 0.5 mL/min. Glycine (75 Da), FAPGG (N-[2-furyl] acryloyl)-Phe-Gly-Gly; (399.40 Da), vitamin B12 (1855 kDa), aprotinin (6512 kDa), and cytochrome C (12.384 kDa) were used as molecular weight standards. Molecular weights of peptide fractions were obtained from a plot of the logarithm of the molecular weight (log M) against the elution time of standard compounds.
+ Open protocol
+ Expand
2

Fractionation of Peptides via Anion-Exchange Chromatography

Check if the same lab product or an alternative is used in the 5 most similar protocols
Anion-exchange chromatography was carried out using an FPLC AKTA purifier system (GE Healthcare, Montreal, PQ, Canada) equipped with a HiprepTM Q-HP 16/10 column and UV detector (λ = 214 nm) to fractionate the MBPH as previously described [26 (link)], which was modified as follows. The column was first equilibrated using 3 column volumes of 20 mM Tris-HCl buffer, pH 8.0. Then 2 mL of sample (0.1 g/mL dissolved in the Tris-HCl buffer) was passed through a 0.2 µm filter before injecting onto the column. The column was washed with 2 column volumes of Tris-HCl buffer to remove unbound peptides. Bound peptides were eluted using a linear gradient of 0% to 100% of Tris-HCl buffer in 1 M NaCl at 1.0 mL/min flow rate. Eluted peptides were monitored at 214 nm and collected into 5 fractions (AF1–AF5) using a fraction collector (Amersham AKTA Frac-900, Montreal, PQ, Canada); the fractions were then freeze-dried.
+ Open protocol
+ Expand
3

Isolation and Purification of Francisella Capsule

Check if the same lab product or an alternative is used in the 5 most similar protocols
Francisella capsule was isolated by subjecting EtOHp to a modified hot phenol/water extraction followed by water/Triton X-114 partitioning and SDS gel filtration as described previously [4 (link)] (S1A Fig). An alternate protocol to isolate capsular polysaccharides from the nuclease-treated EtOHp (S1B Fig) was developed using deoxycholate (DOC)-based gel sieving [12 (link)]. EtOHp samples were dissolved in 2% DOC in 0.2 M NaCl, 50 mM Tris, 5 mM EDTA and sonicated for 30 min in a bath sonicator. After centrifugation to remove any insoluble debris, the sample was applied to a 16 mm x 30 cm Sephacryl S-200 column on an Akta Purifier FPLC system (GE Healthcare) at a flow rate of 0.5 ml/min. In order to remove any residual DOC that might interfere with subsequent chromatographic analysis, fractions underwent three rounds of ethanol precipitation as described above after addition of purified DNA (150 μg/ml UltraPure™ Salmon Sperm DNA Solution, Invitrogen) to enhance recovery. To control for any effects of the DOC or ethanol washing on subsequent chromatographic analysis, whole EtOHp was also treated in the same way in parallel with isolated capsule or low molecular weight material. Washed samples were raised in water and stored at 4°C until further analysis.
+ Open protocol
+ Expand
4

Recombinant Rat Neprilysin Purification and Activity

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant Nln was produced in house as described previously.16 (link) In brief, we used a high-expressing Escherichia coli, clone which was transformed by a plasmid construct for N-terminal polyhistidine-tagged recombinant rat Nln.30 (link) Recombinant Nln was purified to homogeneity (> 95%) from the soluble pool of E. coli lysate using Ni-NTA affinity (Ni-NTA Superflow; Qiagen, Venlo, The Netherlands) and size-exclusion chromatography (Superdex 200 Increase 10/300 GL column in AKTA Purifier FPLC system; GE Healthcare, Chicago, IL, USA). Purification of Nln was followed by removal of endotoxins (endotoxin removal magnetic beads; Miltenyi Biotec, Bergisch Gladbach, Germany) and confirmation of its catalytic activity using a quenched fluorescent substrate.9 (link),18 (link) Small volume aliquots of Nln (1–2 mg mL−1) were kept frozen in −80°C and used within 3–4 months after isolation.
+ Open protocol
+ Expand
5

Recombinant EphA2-Sam and Ship2-Sam Expression

Check if the same lab product or an alternative is used in the 5 most similar protocols
Recombinant EphA2-Sam and Ship2-Sam were expressed in E. coli. Protein constructs along with expression and purification methodologies have been reported in our previous publications11 (link),20 (link),23 (link). Proteins were either produced in LB (Luria-Bertani) broth or M9 minimal medium supplemented with 1 g/L of 15NH4Cl. Bacteria were grown at 37 °C till a cell optical density OD600nm equal to 0.6, then in the induction step isopropyl β-D-1-thiogalactopyranoside (IPTG) at 1 mM concentration (25 °C, overnight) was used. Purification of his-tagged Ship2-Sam and EphA2-Sam was achieved by affinity chromatography with an Akta Purifier FPLC System (GE Healthcare, Milano, Italy) and a Nickel column. Finally, proteins were dialyzed in PBS pH = 7.4.
+ Open protocol
+ Expand
6

Purification of Wdr78 Protein Complex

Check if the same lab product or an alternative is used in the 5 most similar protocols
Eight-week-old mouse testis were homogenized in HMDEK buffer (30 mM HEPES, pH 7.4, 5 mM MgSO4, 1 mM DTT, 0.5 mM EGTA, 1% glycerol, 25 mM KCl) containing 0.1% NP-40, 10 μg/ml nocodazole, and proteinase inhibitors (PMSF and cocktail) (Sloboda, 2009 (link)). The lysates were cleared by centrifugation at 13000 rpm at 4°C for 30 min and filtered through a 0.22-μm filter. The solution was loaded on a prepacked Superose 6 10/300 GL column (GE Healthcare) on a GE AKTA Purifier FPLC system at 4°C. Elution was performed with HMDEK buffer at a flow rate of 0.5 ml/min. Fractions #12–#14 that were abundant in Wdr78 were pooled and applied to an anion-exchange column (Mono Q 4.6/100 PE, GE Healthcare). The bound proteins were eluted with a linear salt gradient of 0.2–1.0 M KCl in HMDEK buffer at a flow rate of 0.5 ml/min. The 0.5-ml fractions were collected for immunoblotting.
+ Open protocol
+ Expand
7

Molecular Weight Determination of SaTrmK

Check if the same lab product or an alternative is used in the 5 most similar protocols
Size-exclusion chromatography was carried out at 20 °C on a Superdex 200 10/300 Gl column pre-equilibrated with 20 mM Hepes pH 7.5, using an AKTA Purifier FPLC system (GE Healthcare). Samples (1 ml) were loaded onto the column at 1 mg/ml. Vitamin B12 (1350 Da), horse myoglobin (17,000 Da), chicken ovalbumin (44,000 Da), bovine γ-globulin (15,8000 Da), and bovine thyroglobulin (670,000 Da) (Bio-Rad) were used as MW standards. The logarithm of the MW of the standards were plotted against the ratios of the respective elution volumes (ve) to the void volume (v0). The points were then fitted to a linear regression, and the values of slope and intercept were used to determine the molecular weight of SaTrmK in solution.
+ Open protocol
+ Expand
8

Gel Filtration Purification of TRX-T-TXNIP

Check if the same lab product or an alternative is used in the 5 most similar protocols
A Superdex 200 10/300 GL gel filtration column (GE Healthcare) installed on an AKTA purifier FPLC system (GE Healthcare) was equilibrated with 50 mM Tris-HCl (pH 8.0), 500 mM NaCl and 10% glycerol at a flow rate of 0.4 ml min−1 at room temperature. The purified TRX–T–TXNIP complex and its mutants were injected onto the column. Ovalbumin was used as the molecular weight standard.
+ Open protocol
+ Expand
9

Purification of Recombinant Protein from Inclusion Bodies

Check if the same lab product or an alternative is used in the 5 most similar protocols
For purification from inclusion bodies, His-VP1-pET28b construct was transformed in E.coli strain BL21 (DE3), and protein overexpression was carried out at 37 °C for 4 h induced with 1 mM IPTG. Post induction, cells were harvested by centrifugation at 6000 rpm for 20 min at 4 °C and resuspended in 20 mM Tris–HCl pH 8.0. Cell lysis was carried out by sonication, and the resultant pellet was resuspended in a denaturing buffer containing 10 mM PBS, pH 7.4 and 8 M urea to solubilize the inclusion bodies. The urea-solubilized denatured protein was allowed to bind to Ni-NTA agarose beads, followed by washes in denaturing buffer containing 20 mM imidazole, and elution in the same buffer containing 350 mM imidazole.
The eluted protein was dialyzed against buffer solutions containing 10 mM PBS, pH 7.4 with gradually decreasing concentrations of urea, at 4 °C with gentle stirring. Post dialysis, the solution was centrifuged at 12,000g for 10 min at 4 °C to remove any precipitated protein. The cleared supernatant was loaded on a Superdex 200 column (10/300) fitted to an AKTA purifier FPLC system (GE Healthcare) equilibrated in the same buffer for further purification by size exclusion chromatography. Fractions were collected and analyzed on SDS-PAGE.
+ Open protocol
+ Expand
10

Sequential Immunoaffinity Purification and Mass Spectrometry Analysis

Check if the same lab product or an alternative is used in the 5 most similar protocols
Flag-HA sequential immunoaffinity purification was carried out as previously described [68 (link)], from 20 mg of nuclear lysates of K562 (MOCK, NPM and NPM-MLF1) cells. Immunoprecipitated proteins were eluted from Flag or HA beads with 4 μg/ml of Flag or HA polypeptides (sequences: Flag: DYKDDDDK or HA:YPYDVPDYA from BioBasic) and molecular size chromatography was performed on the immune-affinity purified complexes with the AKTA purifier FPLC system (GE Healthcare) using Superose 6 increase 10/300 GL column (GE Healthcare). The column was calibrated with Dextran (2000 kDa), Thyroglobulin (669 kDa), Aldolase (158 kDa) and Bovine Serum Albumin (67 kDa) in FPLC buffer (50 mM Tris pH 7.3, 10% Glycerol, 60 mM KCl, 0.2 mM EDTA pH 8.5 mM MgCl2, 1% NP40 and 0.5 mM DTT). 500 μL of nuclear lysate or Tap-Tag purified sample was loaded on the column. After 0.2 column volume of isocratic elution, 0.5 mL fractions were collected, and proteins were precipitated with 15% TCA. Immunopurified samples or fractions, were first analyzed by silver staining, and then LC-MS/MS analysis was performed to identify interacting partners (Taplin Mass Spectrometry Facility, Harvard University, Boston).
Western blots were performed according to standard protocols. The antibodies used are listed in the S1 Table. Images were acquired with Image Quant LAS400 device (GE Healthcare Life Sciences).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!